Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-04

FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk. The approval covers changes to the product's labeling or other regul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NovoLog (insulin aspart)

Snippet

SUPPL AP for NOVOLOG (INSULIN ASPART)